Daprodustat 2 mg tablet
207727
Phase 1 small_molecule completed
Quick answer
Daprodustat 2 mg tablet for Anaemia is a Phase 1 program (small_molecule) at GlaxoSmithKline with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GlaxoSmithKline
- Indication
- Anaemia
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed